Shunqiang Li

9PUBLICATIONS
196CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 20, 2026
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer.

Tito A Sandoval, Yize Li, Naoshad Muhammad

|Feb 12, 2025
Stabilization of RUNX1 Induced by O-GlcNAcylation Promotes PDGF-BB-Mediated Resistance to CDK4/6 Inhibitors in Breast Cancer.

Shuyan Zhou, Yi Zhang, Julie Belmar

|Jul 31, 2024
A Pan-Cancer Patient-Derived Xenograft Histology Image Repository with Genomic and Pathologic Annotations Enables Deep Learning Analysis.

Brian S White, Xing Yi Woo, Soner Koc

|May 08, 2024
Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models.

Zhanfang Guo, Jingqin Luo, R Jay Mashl

|Jan 26, 2024
Development of a [89Zr]Zr-labeled Human Antibody using a Novel Phage-displayed Human scFv Library.

Abhay K Singh, Calvin D Lewis, Cristian A W V Boas

|Dec 15, 2023
Combining the Tyrosine Kinase Inhibitor Cabozantinib and the mTORC1/2 Inhibitor Sapanisertib Blocks ERK Pathway Activity and Suppresses Tumor Growth in Renal Cell Carcinoma.

Yige Wu, Siqi Chen, Xiaolu Yang

Pageof 2

Frequent Collaborators

4 joint publications

Sherri R Davies

4 joint publications

R Jay Mashl

4 joint publications

Li Ding

3 joint publications

Lacey E Dobrolecki